| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 7 613-619, Copyright © 1998 by American Association for Cancer Research
ARTICLES |
G Maskarinec, S Singh, L Meng and AA Franke
Cancer Research Center of Hawaii, Honolulu 96813, USA.
Isoflavones are present in soybeans and its products in concentrations up to 300 mg/100 g, have estrogenic and antiestrogenic properties, and may be protective against hormone-related cancers. The purpose of this cross-sectional study was to investigate the association between urinary isoflavone excretion and self-reported soy intake. A total of 102 women of Caucasian, Native Hawaiian, Chinese, Japanese, and Filipino ancestry completed a dietary questionnaire for soy products consumed during the last year and during the 24-h period before urine collection. Overnight urine samples were analyzed for coumestrol and the soy isoflavones genistein, daidzein, and glycitein and their main human metabolites by reverse-phase high-pressure liquid chromatography. Soy protein and isoflavone intake (predominantly from tofu) were estimated using published nutritional databases. Wilcoxon's rank-sum test scores and Spearman rank correlation coefficients were computed. Japanese women excreted more daidzein, genistein, and glycitein than did Caucasian women, whereas Caucasian women excreted slightly more coumestrol. Soy intake differed significantly among ethnic groups. Dietary soy protein and isoflavone intakes during the previous 24 h were positively related to urinary isoflavone excretion [rs = 0.61 (P < 0.0001) and 0.62 (P < 0.0001), respectively]. Urinary excretion of isoflavones was also related to annual dietary soy protein and isoflavone intake [rs = 0.32 (P < 0.0012) and 0.31 (P < 0.0016), respectively]. The strong correlation between urinary isoflavone excretion and self-reported soy intake validates the dietary history questionnaire that is now used in a study exploring dietary risk factors for breast cancer.
This article has been cited by other articles:
|
|
 |
|
  K. Jaceldo-Siegl, G. E Fraser, J. Chan, A. Franke, and J. Sabate Validation of soy protein estimates from a food-frequency questionnaire with repeated 24-h recalls and isoflavonoid excretion in overnight urine in a Western population with a wide range of soy intakes Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1422 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R Walsh, S. J Haak, T. Bohn, Q. Tian, S. J Schwartz, and M. L Failla Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1050 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-A. Lee, W. Wen, Y.-B. Xiang, S. Barnes, D. Liu, Q. Cai, W. Zheng, and X. O. Shu Assessment of Dietary Isoflavone Intake among Middle-Aged Chinese Men J. Nutr., April 1, 2007; 137(4): 1011 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al. Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC J. Nutr., March 1, 2007; 137(3): 718S - 737S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A Franke, B. M Halm, L. J Custer, Y. Tatsumura, and S. Hebshi Isoflavones in breastfed infants after mothers consume soy. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 406 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Song, C. Atkinson, C. L. Frankenfeld, T. Jokela, K. Wahala, W. K. Thomas, and J. W. Lampe Prevalence of Daidzein-Metabolizing Phenotypes Differs between Caucasian and Korean American Women and Girls J. Nutr., May 1, 2006; 136(5): 1347 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Trock, L. Hilakivi-Clarke, and R. Clarke Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst, April 5, 2006; 98(7): 459 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Maskarinec, A. A. Franke, A. E. Williams, S. Hebshi, C. Oshiro, S. Murphy, and F. Z. Stanczyk Effects of a 2-Year Randomized Soy Intervention on Sex Hormone Levels in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1736 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Maskarinec, Y. Takata, A. A. Franke, A. E. Williams, and S. P. Murphy A 2-Year Soy Intervention in Premenopausal Women Does Not Change Mammographic Densities J. Nutr., November 1, 2004; 134(11): 3089 - 3094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Grace, J. I. Taylor, Y.-L. Low, R. N. Luben, A. A. Mulligan, N. P. Botting, M. Dowsett, A. A. Welch, K.-T. Khaw, N. J. Wareham, et al. Phytoestrogen Concentrations in Serum and Spot Urine as Biomarkers for Dietary Phytoestrogen Intake and Their Relation to Breast Cancer Risk in European Prospective Investigation of Cancer and Nutrition-Norfolk Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 698 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Wu, M. C. Yu, C.-C. Tseng, N. C. Twaddle, and D. R. Doerge Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County Carcinogenesis, January 1, 2004; 25(1): 77 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Dai, A. A. Franke, H. Yu, X.-o. Shu, F. Jin, J. R. Hebert, L. J. Custer, Y.-T. Gao, and W. Zheng Urinary Phytoestrogen Excretion and Breast Cancer Risk: Evaluating Potential Effect Modifiers Endogenous Estrogens and Anthropometrics Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 497 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L Frankenfeld, R. E Patterson, N. K Horner, M. L Neuhouser, H. E Skor, T. F Kalhorn, W. N Howald, and J. W Lampe Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women Am. J. Clinical Nutrition, March 1, 2003; 77(3): 674 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Lampe Isoflavonoid and Lignan Phytoestrogens as Dietary Biomarkers J. Nutr., March 1, 2003; 133(3): 956S - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Setchell, N. M Brown, L. Zimmer-Nechemias, W. T Brashear, B. E Wolfe, A. S Kirschner, and J. E Heubi Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability Am. J. Clinical Nutrition, August 1, 2002; 76(2): 447 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J L Burton and M Wells The effect of phytoestrogens on the female genital tract J. Clin. Pathol., June 1, 2002; 55(6): 401 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Atkinson, H. E. Skor, E. D. Fitzgibbons, D. Scholes, C. Chen, K. Wahala, S. M. Schwartz, and J. W. Lampe Overnight Urinary Isoflavone Excretion in a Population of Women Living in the United States, and Its Relationship to Isoflavone Intake Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 253 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Maskarinec, A. E. Williams, J. S. Inouye, F. Z. Stanczyk, and A. A. Franke A Randomized Isoflavone Intervention among Premenopausal Women Cancer Epidemiol. Biomarkers Prev., February 1, 2002; 11(2): 195 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. R. Setchell Soy Isoflavones--Benefits and Risks from Nature's Selective Estrogen Receptor Modulators (SERMs) J. Am. Coll. Nutr., October 1, 2001; 20(90005): 354S - 362. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. L. Horn-Ross, E. M. John, M. Lee, S. L. Stewart, J. Koo, L. C. Sakoda, A. C. Shiau, J. Goldstein, P. Davis, and E. J. Perez-Stable Phytoestrogen Consumption and Breast Cancer Risk in a Multiethnic Population: The Bay Area Breast Cancer Study Am. J. Epidemiol., September 1, 2001; 154(5): 434 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-J. W. Lu, M. Cree, S. Josyula, M. Nagamani, J. J. Grady, and K. E. Anderson Increased Urinary Excretion of 2-Hydroxyestrone but not 16{{alpha}}-Hydroxyestrone in Premenopausal Women during a Soya Diet Containing Isoflavones Cancer Res., March 1, 2000; 60(5): 1299 - 1305. [Abstract] [Full Text]
|
|
|
|
|
|
J. W. Lampe, D. R. Gustafson, A. M. Hutchins, M. C. Martini, S. Li, K. Wähälä, G. A. Grandits, J. D. Potter, and J. L. Slavin Urinary Isoflavonoid and Lignan Excretion on a Western Diet: Relation to Soy, Vegetable, and Fruit Intake Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 699 - 707. [Abstract] [Full Text]
|
|
|
|
|
|
W. Zheng, Q. Dai, L. J. Custer, X.-O. Shu, W.-Q. Wen, F. Jin, and A. A. Franke Urinary Excretion of Isoflavonoids and the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 35 - 40. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
